Catalyst Wire Dossier Catalyst Wire Dossier

Onartuzumab

onartuzumab · Genentech, Inc.
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for Onartuzumab, covering 2016-09-23 to 2019-07-23. Get the full timeline:

Most recent: Clinical Trial Update: An Extension Study of Onartuzumab in Participants With Solid Tumors on Study Treatment Previously Enrolled in a Company Sponsored Study [Phase 3]

See pricing